Phibro Animal Health | PAHC - 销售毛利

金融业

USD

USD 1.45B

现金及等价物

USD 54.93M

USD 240.42M

USD 894.07M

USD 281.87M

USD 474.17M

股息收益率

1.29

USD 54.99M

USD 68.1M

1.92K

EPS每股收益

USD 0.78

股本和储备

USD 361.83M

USD 133.5M

债务利息支出

USD 11.91M

USD 0.08

USD 597.69M

USD 1.46B

USD 27.46M

USD 361.83M

USD 54.99M

普通股股本

USD 40.48M

13.82

USD 38.63M

USD 373.91M

销售和管理费用

USD 78.32M

USD 539.7M

贸易债权人

USD 129.64M

应收帐款人

USD 215.87M

	销售毛利	更改		日
Align Technology	USD 757.43M		20.84M	2026-06
ANI Pharmaceuticals	USD 124.18M		12.39M	2025-12
Aurora Cannabis	CAD 29.79M		16.83M	2026-03
Bristol-Myers Squibb	USD 9.26B		1.19B	2026-06
Canopy Growth	CAD 8.26M		13.2M	2026-03
Corcept Therapeutics	USD 252.09M		90.07M	2026-06
Eli Lilly	USD 16.22B		301.7M	2026-03
Henry Schein	USD 1.03B		39M	2026-06
Idexx Laboratories	USD 779.09M		56.35M	2026-06
Knight Therapeutics	CAD 64.72M		8.91M	2025-12
Merck	USD 12.09B		1.24B	2026-03
Nektar Therapeutics	USD 10.86M		10.95M	2026-03
Pacira	USD 133.91M		7.27M	2026-06
Phibro Animal Health	USD 133.5M		12.6M	2025-12
Prestige Brands	USD 136.19M		10.11M	2026-06
Supernus Pharmaceuticals	USD 160.06M		30.7M	2026-06
Zoetis	USD 1.62B		20M	2026-03